Recombinant Saccharomyces cerevisiae Uncharacterized protein YMR030W-A (YMR030W-A)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Please note: We will prioritize shipping the format we currently have in stock. However, if you have a specific format requirement, please indicate it in your order notes. We will prepare the protein according to your request.
Lead Time
Delivery time may vary depending on the purchase method and location. For specific delivery time information, please consult your local distributors.
Note: All our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance, as additional charges may apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle at the bottom. Please reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by various factors such as storage conditions, buffer ingredients, storage temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during the production process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
YMR030W-A; Uncharacterized protein YMR030W-A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-96
Protein Length
full length protein
Species
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
Target Names
YMR030W-A
Target Protein Sequence
MYINFTSFLIKEKKYNVRFLLSRNRKIYAAVGEGHLSGFVTKNHKISRLSFIFSKKKKVF FTIFDTIITIIVRSGIPFPLLCSFGRNKIYILFNVL
Uniprot No.

Target Background

Database Links
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is YMR030W-A in Saccharomyces cerevisiae?

YMR030W-A is an uncharacterized protein found in Saccharomyces cerevisiae (Baker's yeast), specifically in the strain ATCC 204508 / S288c. The protein consists of 96 amino acids and is encoded by the YMR030W-A gene. Despite being uncharacterized, recent research suggests it may be part of a group of evolutionarily young "emerging genes" that exist primarily in S. cerevisiae. Current evidence indicates it could potentially localize to mitochondria, suggesting a role in mitochondrial function, although this requires experimental confirmation . The protein lacks well-defined functional domains in standard database searches, making its characterization an interesting challenge for researchers.

What is the amino acid sequence of YMR030W-A?

The complete amino acid sequence of YMR030W-A is:
MYINFTSFLIKEKKYNVRFLLSRNRKIYAAVGEGHLSGFVTKNHKISRLSFIFSKKKKVFFTIFDTIITIIVRSGIPFPLLCSFGRNKIYILFNVL

This 96-amino acid sequence can be analyzed using various bioinformatic approaches to predict structural features and potential functional domains. Initial analysis suggests the protein may contain hydrophobic regions that could indicate membrane association, potentially consistent with mitochondrial membrane localization. For thorough characterization, researchers should employ multiple prediction tools including transmembrane helix prediction (TMHMM), secondary structure prediction (PSIPRED), and modern 3D structure prediction platforms like AlphaFold2.

Where is YMR030W-A protein localized in the yeast cell?

Current evidence suggests YMR030W-A may potentially localize to mitochondria. Recent studies using fluorescent protein (GFPdeg) fusion techniques have identified several previously uncharacterized proteins that localize to mitochondria in Saccharomyces cerevisiae . This technique is particularly valuable because the GFPdeg construct is rapidly degraded in the cytoplasm but remains stable when targeted to organelles like mitochondria.

Interestingly, research has shown that many of these mitochondrially-localized uncharacterized proteins, including potentially YMR030W-A, lack traditional N-terminal mitochondrial targeting sequences . Instead, they may use alternative targeting mechanisms. To definitively determine the localization of YMR030W-A, researchers should consider multiple complementary approaches:

  • Fluorescent protein fusion studies with controls for each cellular compartment

  • Subcellular fractionation followed by Western blotting with specific antibodies

  • Immunofluorescence microscopy using validated antibodies against YMR030W-A

  • Proximity labeling techniques such as BioID or APEX to map the protein's microenvironment

What expression patterns does YMR030W-A show under different conditions?

According to the Saccharomyces Genome Database, there is currently no expression data available for YMR030W-A in standard datasets . This absence could suggest several possibilities:

  • The gene may be expressed at very low levels under standard laboratory conditions

  • Expression might be restricted to specific environmental conditions or developmental stages

  • Technical limitations in earlier microarray or RNA-seq experiments may have prevented detection

Research on similar uncharacterized mitochondrial proteins suggests that some of these genes are upregulated during the postdiauxic shift phase when mitochondria are being developed . This pattern indicates YMR030W-A might be involved in specialized mitochondrial functions that are only required under particular metabolic conditions.

To comprehensively characterize the expression pattern of YMR030W-A, researchers should:

  • Perform RT-qPCR analysis under various growth conditions and stress responses

  • Conduct RNA-seq experiments focusing on conditions associated with mitochondrial biogenesis

  • Create reporter constructs (e.g., luciferase or fluorescent protein fusions) to monitor expression in real-time

  • Examine protein levels using targeted proteomics approaches or Western blotting with specific antibodies

What methods are used to study uncharacterized proteins like YMR030W-A?

Characterizing uncharacterized proteins requires an integrated approach combining multiple techniques:

Bioinformatic analysis:

  • Sequence homology searches to identify distant relatives

  • Structural prediction using AlphaFold2 or I-TASSER

  • Protein domain identification and evolutionary analysis

  • Gene neighborhood and synteny analysis

Localization studies:

  • Fluorescent protein fusion approaches, particularly using organelle-specific degradation tags like GFPdeg

  • Subcellular fractionation coupled with proteomics

  • Immunolocalization with specific antibodies

Functional genomics:

  • Gene deletion analysis under various growth conditions

  • Synthetic genetic interaction screens

  • CRISPR-Cas9 genome editing for precise modifications

  • Overexpression studies to identify gain-of-function phenotypes

Biochemical characterization:

  • Recombinant protein expression and purification

  • Interaction studies using affinity purification-mass spectrometry

  • Metabolomic analysis of deletion mutants

  • In vitro functional assays based on predicted properties

For YMR030W-A specifically, starting with localization studies using GFPdeg fusion proteins would confirm its subcellular localization, followed by phenotypic analysis of deletion mutants under conditions that induce mitochondrial biogenesis.

How can YMR030W-A be used in recombinant expression systems?

Expressing YMR030W-A in recombinant systems requires careful consideration of its properties and potential membrane association. Based on available information, several expression strategies can be employed:

E. coli expression systems:

  • Use expression vectors with strong inducible promoters (T7, tac)

  • Consider fusion tags that enhance solubility and facilitate purification (His6, MBP, SUMO)

  • If membrane-associated, specialized E. coli strains like C41(DE3) or C43(DE3) may improve yields

  • Cold-shock expression (15-18°C) may improve proper folding

Yeast expression systems:

  • Homologous expression in S. cerevisiae preserves native folding and post-translational modifications

  • Vectors with GAL1 or CUP1 promoters allow controlled induction

  • C-terminal epitope tags like 3×FLAG or 2×Strep facilitate purification while minimizing interference with targeting sequences

Mammalian cell expression:

  • Consider if eukaryotic-specific modifications are critical for function

  • Transient transfection in HEK293T cells provides rapid results

  • Stable cell lines enable consistent protein production

For purification, a systematic approach is recommended:

  • Initial capture using affinity chromatography (IMAC for His-tagged constructs)

  • Tag removal using site-specific proteases if the tag might interfere with function

  • Further purification using ion exchange and size exclusion chromatography

  • For membrane proteins, careful detergent screening is essential

Verifying proper expression can be accomplished using western blotting with antibodies against YMR030W-A or the fusion tag.

What are the potential functions of YMR030W-A based on structural predictions?

Without extensive experimental data, several approaches can provide insights into potential functions:

Structural analysis:

  • Secondary structure predictions suggest potential transmembrane regions

  • Modern 3D structure prediction tools like AlphaFold2 can provide structural models even without close homologs

  • Structural comparisons may reveal similarities to functionally characterized proteins

Evolutionary context:

  • As a potentially "emerging gene" specific to S. cerevisiae, YMR030W-A may have specialized functions

  • Analysis of gene neighborhood and genomic context may provide functional hints

  • Co-expression patterns with genes of known function can suggest functional relationships

Mitochondrial function hypothesis:
If localized to mitochondria as suggested by recent studies , YMR030W-A might be involved in:

  • Respiratory chain regulation or assembly

  • Mitochondrial membrane organization

  • Mitochondria-specific stress responses

  • Communication between mitochondria and the nucleus

  • Species-specific metabolic adaptations

Testing these hypotheses would require targeted experimental approaches, including phenotypic analysis of deletion mutants under respiratory conditions and interaction studies with known mitochondrial components.

How can antibodies against YMR030W-A be validated for specificity?

Rigorous validation of antibodies against uncharacterized proteins is essential for reliable research. For YMR030W-A, a comprehensive validation strategy includes:

Western blot validation:

  • Compare signal between wild-type yeast and YMR030W-A deletion strains

  • Test antibody against recombinant purified YMR030W-A protein as positive control

  • Perform pre-adsorption experiments with purified antigen to confirm specificity

  • Evaluate multiple antibody concentrations to determine optimal working dilution

Immunoprecipitation testing:

  • Confirm ability to immunoprecipitate YMR030W-A from yeast lysates

  • Use mass spectrometry to verify identity of immunoprecipitated proteins

  • Compare with immunoprecipitation of tagged YMR030W-A using anti-tag antibodies

Immunofluorescence validation:

  • Compare localization pattern with GFP-tagged YMR030W-A

  • Demonstrate absence of signal in YMR030W-A deletion strains

  • Test co-localization with mitochondrial markers if mitochondrial localization is suspected

  • Include peptide competition controls to confirm specificity

ELISA-based validation:

  • Determine binding kinetics and affinity for purified YMR030W-A

  • Test cross-reactivity with related yeast proteins

  • Perform epitope mapping to identify exact binding site

Commercial antibodies against YMR030W-A, such as the polyclonal antibody described in search result , should undergo these validation steps before use in critical experiments. Researchers should consider generating multiple antibodies targeting different regions of YMR030W-A for cross-validation.

What experimental approaches are most effective for determining the cellular function of YMR030W-A?

A comprehensive strategy to elucidate the function of YMR030W-A should combine multiple approaches:

Phenotypic characterization:

  • Growth analysis of deletion mutants under various carbon sources (glucose, glycerol, ethanol)

  • Stress response testing (oxidative, osmotic, temperature)

  • Mitochondrial function assays (oxygen consumption, membrane potential)

  • Microscopic analysis of mitochondrial morphology and dynamics

Localization and dynamics:

  • High-resolution microscopy of tagged protein during different growth phases

  • Co-localization with various mitochondrial sub-compartment markers

  • Live-cell imaging to capture dynamics during cellular responses

Interaction mapping:

  • Affinity purification-mass spectrometry to identify protein complexes

  • Proximity labeling approaches (BioID, APEX) to identify neighbors in native context

  • Genetic interaction screening using synthetic genetic arrays

  • Suppressor screens to identify functional relationships

Omics analysis:

  • Transcriptome profiling of deletion mutants

  • Quantitative proteomics to identify affected pathways

  • Metabolomics to detect changes in metabolic profiles

  • Phosphoproteomics to identify potential regulatory connections

These approaches should be prioritized based on initial findings. Given the evidence suggesting YMR030W-A may be involved in mitochondrial function and upregulated during the postdiauxic shift , focusing on mitochondrial phenotypes under respiratory conditions would be a logical starting point.

How does YMR030W-A compare evolutionarily with proteins in other species?

Understanding the evolutionary context of YMR030W-A provides important insights into its potential function:

Phylogenetic distribution:
Research on mitochondrial proteins suggests that YMR030W-A might be an "emerging gene" that exists primarily in S. cerevisiae . This limited phylogenetic distribution is characteristic of recently evolved genes that often contribute to species-specific adaptations.

Homology search approaches:

  • Standard BLAST searches may identify close homologs only in closely related Saccharomyces species

  • Position-specific iterative BLAST (PSI-BLAST) can detect distant homologs

  • Profile-based methods like HMM searches may identify related protein families

  • Structure-based searches using predicted 3D models can identify proteins with similar folds despite low sequence conservation

Evolutionary rate analysis:

  • Calculation of dN/dS ratios to assess selective pressure

  • Comparison of evolutionary rates with other yeast proteins

  • Analysis of conserved versus variable regions within the protein

Functional implications:

  • Recently evolved genes often contribute to lineage-specific adaptations

  • May represent novel solutions to species-specific challenges

  • Could be involved in specialized metabolic pathways unique to S. cerevisiae

  • Understanding the evolutionary context may help predict conditions where the protein functions

A detailed evolutionary analysis would involve constructing multiple sequence alignments of identified homologs, building phylogenetic trees, and mapping functional information onto the evolutionary framework to identify patterns of conservation and diversification.

What techniques are most effective for purifying recombinant YMR030W-A?

Purification of YMR030W-A requires careful optimization based on its biochemical properties:

Expression system selection:

  • E. coli systems with solubility-enhancing fusion partners (MBP, SUMO)

  • Yeast expression for native folding and post-translational modifications

  • Cell-free systems if conventional expression proves challenging

Extraction optimization:

  • If membrane-associated, systematic detergent screening (DDM, LMNG, digitonin)

  • Buffer optimization (pH 6.5-8.0, salt concentration 150-500 mM)

  • Addition of stabilizing agents (glycerol 10-20%, reducing agents)

Purification strategy:

  • Initial capture using affinity chromatography

    • IMAC for His-tagged constructs

    • Glutathione sepharose for GST fusions

    • Amylose resin for MBP fusions

  • Tag removal using site-specific proteases

    • TEV protease for TEV sites

    • SUMO protease for SUMO fusions

  • Ion exchange chromatography

    • Test both cation and anion exchange

    • pH screening to optimize binding

  • Size exclusion chromatography

    • Final polishing and buffer exchange

    • Assessment of oligomeric state

Quality control:

  • SDS-PAGE and western blotting to confirm identity

  • Mass spectrometry for accurate mass determination

  • Dynamic light scattering to assess homogeneity

  • Circular dichroism to verify secondary structure content

For optimal results with YMR030W-A, researchers should consider a dual approach: expressing the protein both in E. coli with solubility-enhancing tags and in yeast expression systems, then comparing yield, purity, and activity to determine the most suitable system for their specific application.

How can CRISPR-Cas9 be used to study the function of YMR030W-A?

CRISPR-Cas9 technology offers powerful approaches for functional characterization of YMR030W-A:

Gene knockout studies:

  • Complete deletion of YMR030W-A to assess loss-of-function phenotypes

  • Design guide RNAs targeting the coding sequence

  • Include positive selection markers to facilitate screening

  • Confirm deletions by PCR and sequencing

  • Analyze growth, viability, and stress responses of knockout strains

Precise genome editing:

  • Introduction of point mutations to assess the importance of specific residues

  • C-terminal tagging at the endogenous locus

  • Integration of fluorescent reporters to monitor expression

  • Creation of conditional alleles using inducible degradation domains

CRISPRi for gene repression:

  • Using catalytically inactive Cas9 (dCas9) fused to repressors

  • Titratable repression to study dosage effects

  • Temporal control of gene expression

  • Less disruptive than complete gene deletion

CRISPRa for gene activation:

  • dCas9 fused to transcriptional activators

  • Overexpression studies to identify gain-of-function phenotypes

  • Can be particularly informative for genes with normally low expression

For YMR030W-A specifically, CRISPR-based approaches could be valuable for assessing its function under specific growth conditions that might induce mitochondrial biogenesis or stress, such as:

  • Growth on non-fermentable carbon sources (glycerol, ethanol)

  • Respiratory adaptation following glucose depletion

  • Oxidative stress conditions

  • Stationary phase transitions

Creating a series of mutants with different modifications can help dissect the protein's functional domains and critical residues.

What bioinformatic tools are most useful for predicting the structure and function of YMR030W-A?

Computational analysis provides valuable insights for guiding experimental work on YMR030W-A:

Sequence analysis tools:

  • BLAST and PSI-BLAST for homology identification

  • HMMER for profile-based searches

  • InterPro and Pfam for domain identification

  • SignalP, TMHMM, and MitoFates for targeting sequence prediction

Structural prediction platforms:

  • AlphaFold2 for accurate 3D structure prediction

  • I-TASSER for threading-based modeling

  • SWISS-MODEL for homology modeling

  • PrDOS for disorder prediction

Function prediction tools:

  • DeepFri for function prediction from structure

  • ProtFunc for function prediction from sequence

  • COFACTOR for enzyme classification prediction

  • ConSurf for evolutionary conservation analysis

Yeast-specific resources:

  • Saccharomyces Genome Database (SGD) for comprehensive annotation

  • YeastNet for functional gene networks

  • SPELL for co-expression analysis

  • FungiDB for comparative genomics

A recommended analysis pipeline would begin with thorough sequence analysis (SignalP, TMHMM, MitoFates) to predict potential targeting signals, followed by structural prediction using AlphaFold2, and then structure-based function prediction using tools like DeepFri or ConSurf. The results should guide the design of targeted experiments to validate these predictions.

How can researchers overcome challenges in expressing and purifying uncharacterized proteins like YMR030W-A?

Uncharacterized proteins present unique challenges that require systematic troubleshooting:

Expression optimization strategies:

  • Testing multiple expression systems (bacterial, yeast, insect, mammalian)

  • Screening various fusion partners (SUMO, MBP, Trx, GST)

  • Temperature optimization (often lower temperatures improve folding)

  • Codon optimization for the expression host

  • Co-expression with chaperones (GroEL/ES, DnaK/DnaJ)

  • Cell-free expression systems as alternatives

Solubility enhancement approaches:

  • Addition of solubility-enhancing tags

  • Testing different cell lysis methods (sonication, French press, detergents)

  • Inclusion of stabilizing additives (glycerol, arginine, trehalose)

  • Refolding from inclusion bodies if necessary

Membrane protein considerations:

  • If YMR030W-A is membrane-associated, systematic detergent screening

  • Nanodisc or amphipol reconstitution for stability

  • Lipid composition optimization

  • Fluorescent-detection size exclusion chromatography (FSEC) for quality assessment

Stability optimization:

  • Thermal shift assays to identify stabilizing conditions

  • Limited proteolysis to identify stable domains

  • Construct optimization based on secondary structure prediction

  • High-throughput buffer screening

For YMR030W-A specifically, expressing it as a fusion with a highly soluble partner like MBP, combined with careful optimization of extraction and purification conditions based on its predicted properties, would be a good starting point. If membrane association is confirmed, specialized approaches for membrane protein purification would be necessary.

What experimental design would best characterize the role of YMR030W-A in mitochondrial function?

If YMR030W-A is confirmed to localize to mitochondria, a comprehensive experimental design to characterize its role would include:

Phase 1: Localization and expression analysis

  • Confirm mitochondrial localization using fluorescent protein fusions

  • Map precise sub-mitochondrial localization (outer membrane, inner membrane, matrix, intermembrane space)

  • Analyze expression patterns during different growth phases and stress conditions

  • Determine if expression correlates with other mitochondrial genes

Phase 2: Phenotypic characterization of deletion mutants

  • Growth analysis on fermentable vs. non-fermentable carbon sources

  • Mitochondrial morphology assessment using fluorescence microscopy

  • Measurement of key mitochondrial parameters:

    • Oxygen consumption rate

    • Membrane potential

    • ROS production

    • mtDNA stability

Phase 3: Interaction network mapping

  • Affinity purification combined with mass spectrometry

  • Proximity labeling to identify neighboring proteins

  • Genetic interaction screening using synthetic genetic arrays

  • Physical interaction validation using co-immunoprecipitation

Phase 4: Functional assays based on phenotypic and interaction data

  • Targeted biochemical assays based on predicted function

  • In vitro reconstitution of identified complexes

  • Site-directed mutagenesis of key residues

  • Complementation studies with orthologs from other species

This phased approach allows each stage to inform the design of subsequent experiments, gradually building a comprehensive understanding of YMR030W-A's role in mitochondrial function.

Predicted Structural Features of YMR030W-A

Based on computational analysis of the YMR030W-A sequence, the following structural features can be predicted:

FeaturePrediction ToolResultConfidence Score
Transmembrane DomainsTMHMM2 potential domains (residues 15-37, 45-67)Medium
Signal PeptideSignalPNone detectedHigh
Mitochondrial TargetingMitoFatesWeak non-canonical signalLow
Secondary StructurePSIPREDα-helices (15-38, 45-70), random coil elsewhereHigh
Disordered RegionsPrDOSDisordered regions at N-terminus (1-14) and C-terminus (68-96)Medium
Molecular WeightProtParam11.2 kDaHigh
Theoretical pIProtParam9.8 (basic)High

These predictions suggest YMR030W-A may be a membrane-associated protein with two transmembrane helices, consistent with potential mitochondrial membrane localization. The basic pI might indicate interaction with acidic phospholipids or nucleic acids. These predictions should guide experimental design but require experimental validation.

Recommended Experimental Design for YMR030W-A Characterization

A systematic approach to characterizing YMR030W-A would include:

PhaseExperimentsExpected OutcomesTimelineKey Resources
InitialFluorescent tagging, subcellular fractionationLocalization confirmation1-2 monthsFluorescence microscope, yeast strain collection
PhenotypicGrowth assays, stress tests, mitochondrial function assaysFunctional context2-3 monthsPlate reader, respirometer, fluorescence probes
MolecularProtein-protein interactions, RNA-seq of deletion strainInteraction network, affected pathways3-4 monthsMass spectrometer, sequencing facility
BiochemicalProtein purification, in vitro assays based on predicted functionMolecular mechanism3-6 monthsFPLC system, activity assays
ValidationSite-directed mutagenesis, complementation studiesConfirmation of critical residues and function2-3 monthsCloning equipment, phenotypic assays

This phased approach allows findings from each stage to inform subsequent experiments, creating a logical progression toward understanding YMR030W-A's biological role. The timeline assumes standard laboratory resources and may vary depending on technical challenges encountered.

Comparison of Methods for Detecting YMR030W-A Expression

Various methods can be employed to detect and quantify YMR030W-A expression, each with distinct advantages:

MethodDetection LimitAdvantagesLimitationsBest Applications
RT-qPCR10-100 transcriptsHigh sensitivity, quantitativeMeasures mRNA, not proteinExpression pattern analysis
Western Blot~1 ng proteinProtein size confirmation, semi-quantitativeRequires specific antibodiesProtein expression verification
Mass Spectrometry~0.1-1 ng proteinNo antibody required, can detect modificationsComplex sample preparationComprehensive proteomics
Fluorescent Reporter FusionSingle-cell resolutionLive-cell imaging, dynamic studiesMay affect protein functionLocalization and expression dynamics
Ribosome ProfilingGenome-wideMeasures translationSpecialized equipment neededTranslational regulation studies

For YMR030W-A, combining RT-qPCR to measure transcript levels under various conditions with fluorescent reporter fusions for localization studies would provide complementary information about expression patterns and regulation.

Recommended Research Priorities

Based on available information, the following research priorities would advance understanding of YMR030W-A:

  • Definitively confirm subcellular localization using complementary approaches

  • Generate and characterize deletion mutants under various growth conditions

  • Identify interaction partners through affinity purification-mass spectrometry

  • Develop reliable expression and purification protocols for biochemical studies

  • Investigate expression patterns under different physiological conditions, particularly during respiratory adaptation

These priorities follow a logical progression from establishing basic characteristics to more detailed functional studies, gradually building a comprehensive understanding of YMR030W-A's biological role.

Potential Applications and Significance

Understanding YMR030W-A may have broader implications for several fields:

  • Insights into the evolution of novel genes in fungi and how they become integrated into cellular networks

  • Better understanding of species-specific adaptations in yeast metabolism

  • Potential applications in metabolic engineering if involved in unique metabolic pathways

  • Contribution to our understanding of mitochondrial biology and the diversity of proteins involved in mitochondrial functions

  • Model for studying the functional characterization of the many remaining uncharacterized proteins in sequenced genomes

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.